Symphysiotomy For Feto-Pelvic Disproportion (Review) : Hofmeyr GJ, Shweni PM
Symphysiotomy For Feto-Pelvic Disproportion (Review) : Hofmeyr GJ, Shweni PM
Symphysiotomy For Feto-Pelvic Disproportion (Review) : Hofmeyr GJ, Shweni PM
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2010, Issue 10
http://www.thecochranelibrary.com
1 Department of Obstetrics and Gynaecology, East London Hospital Complex, University of the Witwatersrand, University of Fort
Hare, Eastern Cape Department of Health, East London, South Africa. 2 Department of Obstetrics and Gynaecology, East London
Hospital Complex, East London, South Africa
Contact address: G Justus Hofmeyr, Department of Obstetrics and Gynaecology, East London Hospital Complex, University of the
Witwatersrand, University of Fort Hare, Eastern Cape Department of Health, Frere and Cecilia Makiwane Hospitals, Private Bag X
9047, East London, Eastern Cape, 5200, South Africa. [email protected].
Citation: Hofmeyr GJ, Shweni PM. Symphysiotomy for feto-pelvic disproportion. Cochrane Database of Systematic Reviews 2010,
Issue 10. Art. No.: CD005299. DOI: 10.1002/14651858.CD005299.pub2.
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ABSTRACT
Background
Symphysiotomy is an operation in which the fibres of the pubic symphysis are partially divided to allow separation of the joint and thus
enlargement of the pelvic dimensions during childbirth. It is performed with local analgesia and does not require an operating theatre
nor advanced surgical skills. It may be a lifesaving procedure for the mother or the baby, or both, in several clinical situations. These
include: failure to progress in labour when caesarean section is unavailable, unsafe or declined by the mother; and obstructed birth of
the aftercoming head of a breech presenting baby. Criticism of the operation because of complications, particularly pelvic instability,
and as being a ’second best’ option has resulted in its decline or disappearance from use in many countries. Several large observational
studies have reported high rates of success, low rates of complications and very low mortality rates.
Objectives
To determine, from the best available evidence, the effectiveness and safety of symphysiotomy versus alternative options for obstructed
labour in various clinical situations.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (31 August 2010), the Cochrane Central Register of
Controlled Trials (The Cochrane Library 2010, Issue 3) and PubMed (1966 to 31 August 2010).
Selection criteria
Randomized trials comparing symphysiotomy with alternative management, or alternative techniques of symphysiotomy, for obstructed
labour or obstructed aftercoming head during breech birth.
Planned methods included evaluation of studies against objective quality criteria for inclusion, extraction of data, and analysis of data
using risk ratios or mean differences with 95% confidence intervals. The primary outcomes were maternal death or severe morbidity,
and perinatal death or severe morbidity.
Symphysiotomy for feto-pelvic disproportion (Review) 1
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
Authors’ conclusions
Because of controversy surrounding the use of symphysiotomy, and the possibility that it may be a life-saving procedure in certain
circumstances, professional and global bodies should provide guidelines for the use (or non-use) of symphysiotomy based on the best
available evidence (currently evidence from observational studies). Research is needed to provide robust evidence of the effectiveness
and safety of symphysiotomy compared with no symphysiotomy or comparisons of alternative symphysiotomy techniques in clinical
situations in which caesarean section is not available; and compared with caesarean section in clinical situations in which the relative
risks and benefits are uncertain (for example in women at very high risk of complications from caesarean section).
Symphysiotomy is an operation to enlarge the capacity of the mother’s pelvis by partially cutting the fibres joining the pubic bones
at the front of the pelvis. Usually, when the baby is too big to pass through the pelvis, a caesarean section is performed. If caesarean
section is not available, or the mother is too ill for, or refuses, caesarean section or if there is insufficient time to perform caesarean
section (for example when the baby’s body has been born feet first, and the head is stuck), symphysiotomy may be performed. Local
anaesthetic solution is injected to numb the area, then a small cut is made in the skin with a scalpel, and most of the fibres of the
symphysis are cut. As the baby is born, the symphysis separates just enough to allow the baby through. Large observational studies have
shown that symphysiotomy is extremely safe with respect to life-threatening complications, but rarely may result in pelvic instability.
For this reason, and because the operation is viewed as a ‘second-class’ operation, it is seldom performed today. Health professionals
fear censure should they perform a symphysiotomy which leads to complications. Proponents argue that many deaths of mothers and
babies from obstructed labour in parts of the world without caesarean section facilities could be prevented if symphysiotomy was used.
This review found no randomized trials evaluating symphysiotomy.
REFERENCES
APPENDICES
Selection of studies
Both review authors will independently assess for inclusion all the potential studies we identify as a result of the search strategy. We
will resolve any disagreement through discussion.
Dichotomous data
For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the
standardised mean difference to combine trials that measure the same outcome, but use different methods.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using the T2 , I² and Chi² statistics. We will regard heterogeneity as
substantial if I2 is greater than 30% and either T2 is greater than zero, or there is a low P-value (< 0.10) in the Chi² test for heterogeneity.
Data synthesis
We will carry out statistical analysis using the Review Manager software (RevMan 2008). We will use fixed-effect meta-analysis for
combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are
examining the same intervention, and the trials’ populations and methods are judged sufficiently similar. If there is clinical heterogeneity
sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we
will use random-effects meta-analysis to produce an overall summary if an average treatment effect across trials is considered clinically
meaningful. The random-effects summary will be treated as the average range of possible treatment effects and we will discuss the
clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful we will not
combine trials.
If we use random-effects analyses, the results will be presented as the average treatment effect with its 95% confidence interval, and the
estimates of T2 and I2 .
Sensitivity analysis
We will conduct sensitivity analyses to assess the effect of inclusion of studies with higher risks of bias as outlined above. Sensitivity
analyses will include all outcomes.
CONTRIBUTIONS OF AUTHORS
GJ Hofmeyr conducted the literature search and contributed to the writing of the review. PM Shweni provided clinical input to the
writing of the paper.
DECLARATIONS OF INTEREST
None known.
SOURCES OF SUPPORT
Internal sources
• (GJH) Effective Care Research Unit, University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of
Health, South Africa.
• (PMS) Eastern Cape Department of Health, South Africa.
External sources
• (GJH) HRP-UNDP/UNFPA/WHO/World Bank Special Programme in Human Reproduction, Geneva, Switzerland.
• (GJH) Rockefeller Foundation Residency, October 2004, USA.